Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Dana-Farber Cancer Institute
National Cancer Institute (NCI)
Janssen Research & Development, LLC
National Cancer Institute (NCI)
Janssen Research & Development, LLC
University of Pittsburgh
Seagen Inc.
Coherus Oncology, Inc.
Peking Union Medical College
Memorial Sloan Kettering Cancer Center
Wake Forest University Health Sciences
Ohio State University Comprehensive Cancer Center
AstraZeneca
Memorial Sloan Kettering Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University of Chicago
M.D. Anderson Cancer Center
Neonc Technologies, Inc.
Memorial Sloan Kettering Cancer Center
Institut Claudius Regaud
University of Chicago
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Tang-Du Hospital
Rakuten Medical, Inc.
Maastricht University Medical Center
University of Michigan Rogel Cancer Center
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Iovance Biotherapeutics, Inc.
University of Pittsburgh
Akeso
University of Malaya
Taiho Pharmaceutical Co., Ltd.
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Rutgers, The State University of New Jersey
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Beijing Tongren Hospital
Nanfang Hospital, Southern Medical University
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University